Form 13G CALCIMEDICA For: 8 May
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CalciMedica Inc (CALC)
The CalciMedica share price today is 0.617, view NASDAQ CALC stock exchange data. Track the latest CalciMedica share price with real-time updates on CALC stock performance including market cap, day range, 52-week range and dividend yield. Access CALC charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.581
0.642
52 wk Range
0.461
7.200
CALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5810.642
52 wk Range
0.4617.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CALC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.333
Upside
+1,574.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 13G CALCIMEDICA For: 8 May
- Investing.com
- Form S-3 CalciMedica Inc For: 3 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.333
(+1,574.77% Upside)
Earnings
Latest Release
12-05-2026
EPS / Forecast
0.30 / -0.51
Revenue / Forecast
-- / --
Compare CALC to Peers and Sector
Metrics to compare | CALC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCALCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −2.3x | −0.5x | |
PEG Ratio | −0.03 | −0.05 | 0.00 | |
Price/Book | −8.8x | 2.7x | 2.6x | |
Price / LTM Sales | - | 5,133.3x | 3.2x | |
Upside (Analyst Target) | - | 490.0% | 55.3% | |
Fair Value Upside | Unlock | −9.4% | 9.7% | Unlock |
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CalciMedica (CALC) Share Price Today?
The CalciMedica share price today is 0.617.
What is the current CalciMedica (CALC) share price and day range?
As of 20-05-2026, the CalciMedica share price is 0.617, with a previous close of 0.620. The share price has ranged from 0.581 to 0.642 today, while the 52-week range spans from 0.461 to 7.200.
What Is the CalciMedica Market Cap?
As of today, CalciMedica market cap is 9.820M.
What Is the CalciMedica (CALC) Share Price Target?
The average 12-month share price target for CalciMedica is 10.333, with a high estimate of 15 and a low estimate of 6. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +1,574.77% Upside potential.
What Is CalciMedica's Earnings Per Share (TTM)?
The CalciMedica EPS (TTM) is -1.268.
From a Technical Analysis Perspective, Is CALC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does CalciMedica Trade On?
CalciMedica is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for CalciMedica?
The stock symbol for CalciMedica is "CALC."
How Many Times Has CalciMedica Stock Split?
CalciMedica has split 1 times.
How Many Employees Does CalciMedica Have?
CalciMedica has 16 employees.
What Is the CALC After Hours Price?
CALC's last after hours stock price is 0.615, the stock has changed by -0.002, or -0.370%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.